Harald Reinhart files SEC Form 4 disclosures for Zai Lab Ltd. They have made 13 open-market trades across 1 company since 2021, most recently 2024-06-26.
CIK 0001835824
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 13 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ZLAB | 62,619 | $1.5M |
Shares reported on the most recent Form 4, priced at the 2024-06-27 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ZLAB | SELL | 2024-06-26 | 2024-06-27 | $17.90 | $266K | -0.5% | +9.7% | +18.7% |
| ZLAB | SELL | 2024-04-04 | 2024-04-05 | $15.67 | $33K | -12.6% | +7.7% | +10.3% |
| ZLAB | SELL | 2024-04-02 | 2024-04-03 | $16.15 | $29K | -9.7% | +3.3% | +10.4% |
| ZLAB | SELL | 2024-01-03 | 2024-01-03 | $26.12 | $251K | -7.9% | -14.9% | -39.3% |
| ZLAB | SELL | 2023-03-03 | 2023-03-07 | $40.00 | $459K | -9.0% | -10.4% | -4.8% |
| ZLAB | SELL | 2022-11-15 | 2022-11-17 | $40.00 | $74K | +10.2% | -14.1% | +6.2% |
| ZLAB | SELL | 2021-09-09 | 2021-09-10 | $140.40 | $2.1M | -14.2% | -26.3% | -50.9% |
| ZLAB | SELL | 2021-09-07 | 2021-09-08 | $151.01 | $1.6M | -14.8% | -29.7% | -51.6% |
| ZLAB | SELL | 2021-08-23 | 2021-08-25 | $139.18 | $2.2M | +5.4% | -16.2% | -49.7% |
| ZLAB | SELL | 2021-07-13 | 2021-07-15 | $169.65 | $2.0M | -32.4% | -15.1% | -40.5% |
| ZLAB | SELL | 2021-06-16 | 2021-06-17 | $162.18 | $2.6M | +11.6% | -3.4% | -21.7% |
| ZLAB | SELL | 2021-05-24 | 2021-05-26 | $162.02 | $2.6M | +3.1% | +5.9% | -11.7% |
| ZLAB | SELL | 2021-04-20 | 2021-04-21 | $156.10 | $2.5M | +1.2% | +3.5% | +1.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.